Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,600 signal articles · 222 in last 24h · 133,761 total before filter · latest 26m ago
222last 24h
1120last 7d
179● bullish (7d)
130● bearish (7d)
208publishers
AllMacro286Earnings395M&A70Regulatory28Product10Analyst17
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Flag Ship Acquisition Targets AI Compute, Aircraft Engines for Cash Flow
MarketBeat30d agoneutral
Flag Ship Acquisition Targets AI Compute, Aircraft Engines for Cash Flow

Flag Ship Acquisition (NASDAQ:ETHZ) executives, speaking during a Forum Markets presentation hosted by Force Family Office, outlined a strategy centered on acquiring cash-generating real-world assets while maintaining the option to fractionalize and tokenize those assets as the market develops. Joh

Bloomberg30d agoneutral
Chipotle Pulled Jalapeños Tied to Minnesota Salmonella Cases

(Bloomberg) -- Chipotle Mexican Grill Inc. removed jalapeños from multiple stores in Minnesota after learning the peppers may be linked to a salmonella outbreak in the state that’s sickened 110 people.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallApple’s New CEO Taps Retired Hardware Executive for Management TeamQatar, Bessent Signal Progres

SRX Global Acquires Stake in Vistagen Therapeutics
InvestorsHub30d agoneutral
SRX Global Acquires Stake in Vistagen Therapeutics

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).

Brokers split on AstraZeneca merger talk as shares recover some ground
Proactive30d agoneutral
Brokers split on AstraZeneca merger talk as shares recover some ground

Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) share price after Monday's sharp fall, while Deutsche Bank sees clear parallels with the drugmaker's Alexion acquisition five years ago. The two notes are the second-day response to a...

AstraZeneca (LSE:AZN) Is In Merger Talks With Bristol Myers For $400 Billion
Simply Wall St.30d agoneutral
AstraZeneca (LSE:AZN) Is In Merger Talks With Bristol Myers For $400 Billion

AstraZeneca (LSE:AZN) is reported to be in advanced merger talks with Bristol Myers Squibb. The potential deal could create a combined pharmaceutical company valued at about US$400b. The transaction, if completed, would rank among the largest in the sector and could significantly affect competitive positions in oncology. Regulators are expected to review any agreement closely due to overlapping product portfolios. AstraZeneca is a global pharmaceutical company with a significant focus on...

Chinese robot maker Unitree seen worth over $7.4 billion yuan after IPO, Citic says
Reuters30d agoneutral
Chinese robot maker Unitree seen worth over $7.4 billion yuan after IPO, Citic says

Chinese robot maker Unitree Technology is expected to be valued ‌at more than 50 billion yuan ($7.4 billion) after its planned ‌Shanghai IPO, according to a report by Citic Securities, which is sponsoring the initial ​public offering. Citic Securities expected the Hangzhou-based company to be worth 50.6 billion to 55.9 billion yuan six to 12 months after listing later this month. The valuation report, distributed to investors and seen by ‌Reuters, is largely seen ⁠as guidance ahead of Wednesday's IPO price enquiry.

SpaceX Set for First Quarterly Results Since IPO as Investors Assess Valuation
InvestorsHub30d agoneutral
SpaceX Set for First Quarterly Results Since IPO as Investors Assess Valuation

SpaceX (NASDAQ:SPCX) is due to publish its quarterly results after the close of trading on Tuesday, marking the company’s first earnings report since its highly anticipated stock market debut. The release is expected to provide investors with a clearer picture of whether the company’s financial performance supports the ambitious growth expectations that accompanied its listing, particularly as it continues to invest heavily in artificial intelligence and space technologies.

How a pharma megamerger could squelch R&D
Axios30d agoneutral
How a pharma megamerger could squelch R&D

Big drug companies have been buying scrappy biotechs to expand their pipelines, but the potential megamerger between AstraZeneca and Bristol Myers Squibb could flip that script.

APH Q2 Deep Dive: AI Datacenter Demand and CommScope Acquisition Propel Growth
StockStory30d agoneutral
APH Q2 Deep Dive: AI Datacenter Demand and CommScope Acquisition Propel Growth

Electrical connector manufacturer Amphenol (NYSE:APH) announced better-than-expected revenue in Q2 CY2026, with sales up 55% year on year to $8.76 billion. On top of that, next quarter’s revenue guidance ($9.35 billion at the midpoint) was surprisingly good and 7.1% above what analysts were expecting. Its non-GAAP profit of $1.35 per share was 13.2% above analysts’ consensus estimates.

Forkast News30d agoneutral
Mastercard Completes BVNK Acquisition: The Network Becomes the Bridge

Mastercard finally closed its acquisition of London-based stablecoin infrastructure provider BVNK on August 3, 2026. If you have ever wondered what happens when the plumbing of global finance decides to move inside the house, this is your answer. It is not just another corporate press release about a strategic partnership; it is the moment the […]

Major crypto exchange eyes IPO amid market slump
TheStreet31d agobearish
Major crypto exchange eyes IPO amid market slump

The Bithumb crypto exchange is preparing for a 2028 initial public offering (IPO) after reorganizing its business and setting out a two-year program to strengthen accounting, compliance and risk controls. South Korea’s largest cryptocurrency exchange said it expects to complete internal-control ...